Legal Representation
Attorney
Cynthia J. Walden
USPTO Deadlines 3 active 3 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Dec 27, 2022 | 923 days overdue | Low | No |
|
OPPOSITION
Notice of Publication |
NPUB | Feb 16, 2023 | 872 days overdue | Medium | Until Mar 16, 2023 |
|
ITU SOU
Notice of Allowance Mailed - SOU Required |
NOAM | Sep 14, 2023 | 662 days overdue | High | Until Mar 14, 2024 |
Application History
32 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 12, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Mar 11, 2025 | EXT4 | S | SOU EXTENSION 4 FILED |
| Mar 11, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 6, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
| Sep 6, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Sep 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 6, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 15, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 14, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Mar 14, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 14, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| Sep 15, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 13, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
| Sep 13, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 13, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Mar 14, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 28, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 12, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 12, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 12, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Dec 12, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 12, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 23, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 23, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jun 23, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jun 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 23, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 22, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 21, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
proteins for use in the manufacture of immunotherapeutics; reagents for research purposes
Class 005
pharmaceutical preparations for the treatment of age-related and inflammatory diseases and disorders
Additional Information
Design Mark
The mark consists of a figure "8" followed by the letters "H" with an arrow, the letter "C" and the letter "W" with slanted lines separating the two outer strokes from the middle of the letter, with the word "BIOLOGICS" underneath the letters "C" and "W".
Pseudo Mark
EIGHT HCW BIOLOGICS
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOLOGICS"